The Iran war subpoenas are not the only sign of institutional stress in Washington. The New York Times reported that FDA Commissioner Marty Makary has resigned after weeks of pressure. Makary had at times tried to advance his own principles alongside the administration’s goals, which clashed with the interests of powerful food, tobacco, and pharmaceutical industries. His departure raises questions about the independence of regulatory agencies under the current administration.
Separately, the U.S. Senate approved Kevin Warsh for the Federal Reserve’s board, with confirmation as Fed chair expected later this week — a move that could reshape American monetary policy. And the Times also reported on mysterious meddling in Democratic primaries bearing “G.O.P. fingerprints,” suggesting that anonymous political action committees are attempting to influence which Democrats make it to the general election in the 2026 midterms.
